These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35249034)

  • 1. Avoiding "False Positive" and "False Negative" Immunohistochemical Results in Breast Pathology.
    Li Z; Dabbs DJ
    Pathobiology; 2022; 89(5):309-323. PubMed ID: 35249034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas.
    Turashvili G; Bouchal J; Ehrmann J; Fridman E; Skarda J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):59-64. PubMed ID: 17690741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast.
    de Deus Moura R; Wludarski SC; Carvalho FM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):1-12. PubMed ID: 22595945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
    Canas-Marques R; Schnitt SJ
    Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing.
    Bergeron A; Desmoulins I; Beltjens F; Causeret S; Charon-Barra C; Martin E; Richard C; Boidot R; Arnould L
    J Clin Pathol; 2020 Sep; 73(9):597-601. PubMed ID: 31980561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
    Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
    Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study.
    Pai RK; West RB
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):202-6. PubMed ID: 19391212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.
    Bratthauer GL; Moinfar F; Stamatakos MD; Mezzetti TP; Shekitka KM; Man YG; Tavassoli FA
    Hum Pathol; 2002 Jun; 33(6):620-7. PubMed ID: 12152161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
    Wallace ML; Smoller BR
    Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
    Lee AH
    J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
    Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
    Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry for diagnosis and prognosis of breast cancer: a review.
    Bonacho T; Rodrigues F; Liberal J
    Biotech Histochem; 2020 Feb; 95(2):71-91. PubMed ID: 31502889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
    Chiu K; Ionescu DN; Hayes M
    Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practical applications of diagnostic immunohistochemistry in breast pathology.
    Lerwill MF
    Am J Surg Pathol; 2004 Aug; 28(8):1076-91. PubMed ID: 15252316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.
    Turashvili G; Bouchal J; Burkadze G; Kolár Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):57-62. PubMed ID: 16170389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration cytology of pleomorphic lobular carcinoma of the breast. Duct carcinoma as a diagnostic pitfall.
    Dabbs DJ; Grenko RT; Silverman JF
    Acta Cytol; 1994; 38(6):923-6. PubMed ID: 7992580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.